Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Rudin

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Human Vaccines & Immunotherapeutics|April 15, 2024
Seasonal influenza vaccine performance and the potential benefits of mRNA vaccinesColin A Russell, Ron A M Fouchier, Parinaz Ghaswalla, et al.
British Journal of Pharmacology|May 5, 2026
5-HT<sub>2A</sub> receptor agonism by tert-leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidenceGiorgia Corli, Deborah Rudin, Dino Luethi, et al.
European Journal of Internal Medicine|August 7, 2019
Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patientsDeborah Rudin, Julia Spoendlin, Anca L Cismaru, et al.
Translational Psychiatry|June 4, 2026
Comparison of acute effects of 3,4-methylenedioxymethamphetamine (MDMA) with and without a supplemental booster dose in healthy participants: a double-blind, randomized, placebo-controlled, crossover studyMélusine Humbert-Droz, Anna M Becker, Jan Valenta, et al.
NPJ Vaccines|November 21, 2025
Reproducible and later vaccine strain selection can improve vaccine match to A/H3N2 seasonal influenza virusesAnnelies J H de Rooij, Vincent J C Lempers, Yoonyoung Park, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 25, 2025
Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participantsIsabelle Straumann, Patrick Vizeli, Isidora Avedisian, et al.
Molecular Psychiatry|September 2, 2025
Cell membrane cholesterol affects serotonin transporter efflux due to altered transporter oligomerizationDeborah Rudin, Dino Luethi, Marco Niello, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 28, 2026
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participantsDenis Arikci, Joran Borgulya, Isabelle Straumann, et al.
Vaccine|January 9, 2022
Safety of recombinant quadrivalent influenza vaccine compared to inactivated influenza vaccine in Chinese adults: An observational studyAmber Hsiao, John Hansen, Karen Valdez Nunley, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 9, 2024
Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic researchFriederike Holze, Martin K Madsen, Claus Svarer, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Human Vaccines & Immunotherapeutics|April 15, 2024
Seasonal influenza vaccine performance and the potential benefits of mRNA vaccinesColin A Russell, Ron A M Fouchier, Parinaz Ghaswalla, et al.
British Journal of Pharmacology|May 5, 2026
5-HT<sub>2A</sub> receptor agonism by tert-leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidenceGiorgia Corli, Deborah Rudin, Dino Luethi, et al.
European Journal of Internal Medicine|August 7, 2019
Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patientsDeborah Rudin, Julia Spoendlin, Anca L Cismaru, et al.
Translational Psychiatry|June 4, 2026
Comparison of acute effects of 3,4-methylenedioxymethamphetamine (MDMA) with and without a supplemental booster dose in healthy participants: a double-blind, randomized, placebo-controlled, crossover studyMélusine Humbert-Droz, Anna M Becker, Jan Valenta, et al.
NPJ Vaccines|November 21, 2025
Reproducible and later vaccine strain selection can improve vaccine match to A/H3N2 seasonal influenza virusesAnnelies J H de Rooij, Vincent J C Lempers, Yoonyoung Park, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 25, 2025
Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participantsIsabelle Straumann, Patrick Vizeli, Isidora Avedisian, et al.
Molecular Psychiatry|September 2, 2025
Cell membrane cholesterol affects serotonin transporter efflux due to altered transporter oligomerizationDeborah Rudin, Dino Luethi, Marco Niello, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 28, 2026
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participantsDenis Arikci, Joran Borgulya, Isabelle Straumann, et al.
Vaccine|January 9, 2022
Safety of recombinant quadrivalent influenza vaccine compared to inactivated influenza vaccine in Chinese adults: An observational studyAmber Hsiao, John Hansen, Karen Valdez Nunley, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 9, 2024
Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic researchFriederike Holze, Martin K Madsen, Claus Svarer, et al.
Pageof 5